سهم تغيير تاريخ
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Insmed USD 132.07M 11.1M 2025-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Kyowa Hakko Kirin JPY 72.86B 304M 2025-06
MacroGenics USD 7.91M 840K 2025-12
Moderna USD 146M 7M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52M 200K 2025-12
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03